Diet reduction to requirements in obese/overfed ewes from early gestation prevents glucose/insulin dysregulation and returns fetal adiposity and organ development to control levels.
Obesity at conception and excess gestational weight gain pose significant risks for adverse health consequences in human offspring. This study evaluated the effects of reducing dietary intake of obese/overfed ewes beginning in early gestation on fetal development. Sixty days prior to conception, ewes were assigned to a control diet [CON: 100% of National Research Council (NRC) recommendations], a diet inducing maternal obesity (MO: 150% of NRC recommendations), or a maternal obesity intervention diet (MOI: 150% of NRC recommendations to day 28 of gestation, then 100% NRC) until necropsy at midgestation (day 75) or late (day 135) gestation. Fetal size and weight, as well as fetal organ weights, were greater (P < 0.05) at midgestation in MO ewes than those of CON and MOI ewes. By late gestation, whereas fetal size and weight did not differ among dietary groups, cardiac ventricular weights and wall thicknesses as well as liver and perirenal fat weights remained elevated in fetuses from MO ewes compared with those from CON and MOI ewes. MO ewes and fetuses exhibited elevated (P < 0.05) plasma concentrations of triglycerides, cholesterol, insulin, glucose, and cortisol at midgestation compared with CON and MOI ewes and fetuses. In late gestation, whereas plasma triglycerides and cholesterol, insulin, and cortisol remained elevated in MO vs. CON and MOI ewes and fetuses, glucose concentrations were elevated in both MO and MOI fetuses compared with CON fetuses, which was associated with elevated placental GLUT3 expression in both groups. These data are consistent with the concept that reducing maternal diet of obese/overfed ewes to requirements from early gestation can prevent subsequent alterations in fetal growth, adiposity, and glucose/insulin dynamics.
Center for the Study of Fetal Programming, Department of Animal Science, University of Wyoming, Laramie, Wyoming;
Nuermaimaiti
N
Tuersunjiang
John F
JF
Odhiambo
Nathan M
NM
Long
Desiree R
DR
Shasa
Peter W
PW
Nathanielsz
Stephen P
SP
Ford
D050154:Adiposity / Q000502:physiology*; D000824:Animal Nutritional Physiological Phenomena; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism*; D001835:Body Weight; D004038:Diet, Reducing; D005260:Female; D005333:Fetus / Q000378:metabolism* / Q000503:physiopathology; D007328:Insulin / Q000378:metabolism*; D039382:Maternal Nutritional Physiological Phenomena; D009765:Obesity / Q000178:diet therapy / Q000378:metabolism*; D038081:Organogenesis / Q000502:physiology*; D044343:Overnutrition / Q000378:metabolism; D050177:Overweight / Q000178:diet therapy / Q000378:metabolism*; D011247:Pregnancy; D012756:Sheep
D001786:Blood Glucose; D007328:Insulin
dietary intervention; fetal growth and metabolism; maternal obesity